Featured Insights
Overweight S&P Biotech
We doubt the merger mania is over and we continue to believe that more mega deals are in store, either intra or inter-industry, with Big Pharma hungry and in a hurry to replenish their drug pipeline. From a long-term macro perspective, biotech stocks…
Interested in reading the full Daily Insight?
Read the full insight with instant access.
BCA Research | Daily Insights
Base-level subscription for all clients. Includes Bank Credit Analyst, BCA Live (formerly BCA Live & Unfiltered), and BCA Daily Insights.
Stay Connected with BCA
Get our latest events and research insights delivered to your inbox.